BDX
BECTON DICKINSON & CO
Key Financials
Net Income
$1.7B
↓ 1.6%
Operating Income
$2.6B
↑ 7.6%
Revenue
$21.8B
↑ 8.2%
Gross Profit
$7.6B
↑ 243.5%
EPS (Diluted)
$5.82
↓ 0.7%
Total Assets
$55.3B
↓ 3.4%
Shareholders' Equity
$25.4B
↓ 1.9%
Cash & Equivalents
$641.0M
↓ 62.7%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 8-K | 4/9/2026 | View on SEC |
| 4 | 4/6/2026 | View on SEC |
| 8-K | 4/2/2026 | View on SEC |
| 4 | 3/27/2026 | View on SEC |
| 144 | 3/26/2026 | View on SEC |
| SCHEDULE 13G/A | 3/26/2026 | View on SEC |
| 4 | 3/17/2026 | View on SEC |
| 3 | 3/17/2026 | View on SEC |
| 4 | 3/4/2026 | View on SEC |
| 4 | 3/4/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | BDX |
| Company Name | BECTON DICKINSON & CO |
| CIK | 10795 |
| Sector | Surgical & Medical Instruments & Apparatus |
| Industry | Large accelerated filer |
| Exchange | NYSE |
| SIC Code | 3841 |
| SIC Description | Surgical & Medical Instruments & Apparatus |
| Entity Type | operating |
| Fiscal Year End | 0930 |
| State of Incorporation | NJ |
| Phone | 2018476800 |